Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,552 | 465 | 99.8% |
| Education | $24.75 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,877 | 28 | $0 (2024) |
| Novo Nordisk Inc | $1,705 | 47 | $0 (2024) |
| ABBVIE INC. | $1,469 | 55 | $0 (2024) |
| Lilly USA, LLC | $1,387 | 83 | $0 (2024) |
| PFIZER INC. | $1,347 | 70 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $1,306 | 31 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,277 | 51 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $968.31 | 33 | $0 (2024) |
| Amarin Pharma Inc. | $242.65 | 3 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $234.25 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,736 | 42 | Amgen Inc. ($557.86) |
| 2023 | $897.17 | 35 | AbbVie Inc. ($391.08) |
| 2022 | $891.83 | 55 | Lilly USA, LLC ($247.59) |
| 2021 | $1,572 | 53 | AbbVie Inc. ($684.80) |
| 2020 | $1,636 | 78 | Amgen Inc. ($396.45) |
| 2019 | $2,691 | 85 | Amgen Inc. ($526.91) |
| 2018 | $2,510 | 76 | PFIZER INC. ($604.18) |
| 2017 | $1,643 | 44 | SANOFI-AVENTIS U.S. LLC ($655.66) |
All Payment Transactions
468 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Oncology | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/19/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $112.50 | General |
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Diabetes | ||||||
| 09/04/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $40.19 | General |
| Category: OUD | ||||||
| 08/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | Cash or cash equivalent | $111.61 | General |
| Category: Opioid Use Disorder | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Respiratory | ||||||
| 07/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Diabetes | ||||||
| 06/20/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Oncology | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: Respiratory | ||||||
| 05/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Inflammation | ||||||
| 05/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology | ||||||
| 05/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/09/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $7.16 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Respiratory | ||||||
| 05/02/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Opioid Use Disorder | ||||||
| 04/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 04/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 20 | 58 | $9,378 | $4,476 |
| 2022 | 1 | 17 | 70 | $10,501 | $5,912 |
| 2021 | 3 | 47 | 112 | $11,586 | $7,891 |
| 2020 | 3 | 52 | 114 | $14,923 | $6,677 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 58 | $9,378 | $4,476 | 47.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 70 | $10,501 | $5,912 | 56.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 64 | $8,929 | $6,051 | 67.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 28 | $2,657 | $1,840 | 69.2% |
| 91300 | Sarscov2 vac 30mcg/0.3ml im | Office | 2021 | 18 | 20 | $0.20 | $0.20 | 100.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 25 | 72 | $11,682 | $5,079 | 43.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 28 | $2,849 | $1,370 | 48.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 14 | 14 | $392.00 | $227.78 | 58.1% |
About Dr. Sandra Boehlert, MD
Dr. Sandra Boehlert, MD is a Internal Medicine healthcare provider based in Albion, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457343972.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sandra Boehlert, MD has received a total of $13,577 in payments from pharmaceutical and medical device companies, with $1,736 received in 2024. These payments were reported across 468 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($13,552).
As a Medicare-enrolled provider, Boehlert has provided services to 136 Medicare beneficiaries, totaling 354 services with total Medicare billing of $24,956. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Albion, NY
- Active Since 08/19/2005
- Last Updated 04/29/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1457343972
Products in Payments
- Repatha (Biological) $986.72
- TRELEGY ELLIPTA (Drug) $951.72
- UBRELVY (Drug) $922.86
- Ozempic (Drug) $832.75
- EUCRISA (Drug) $821.53
- QULIPTA (Drug) $570.01
- SOLIQUA (Drug) $548.29
- Aimovig (Biological) $479.86
- TRULICITY (Drug) $471.95
- FARXIGA (Drug) $364.67
- TOUJEO (Drug) $350.18
- CHANTIX (Drug) $324.34
- MOUNJARO (Drug) $308.91
- SYMBICORT (Drug) $303.86
- Victoza (Drug) $280.27
- RYBELSUS (Drug) $261.34
- Vascepa (Drug) $242.65
- Tresiba (Drug) $241.66
- ENTRESTO (Drug) $234.25
- Cologuard Collection Kit (Device) $202.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.